How many patents does
Cnrs have?
patents
38,857
families
7,363
granted
10,248
applications
28,609
US
7,119
EP
7,083
WO
5,905
CN
2,035
JP
1,800
KR
787
GB
50
RoW
14,078
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Cnrs
Top ten assignees appearing on patents
2009 - 2018
| arkema | 652 |
| thales | 484 |
| rhodia operations | 349 |
| electricite de france | 305 |
| stmicroelectronics | 211 |
| l'air liquide societe anonyme pour… 🛈 | 205 |
| total | 199 |
| peugeot citroen automobiles | 194 |
| idenix pharmaceuticals | 183 |
| les laboratoires servier | 170 |
2018
| thales | 70 |
| arkema | 59 |
| electricite de france | 40 |
| rhodia operations | 38 |
| total | 28 |
| abivax | 28 |
| total marketing services | 26 |
| bostik | 26 |
| l'air liquide societe anonyme pour… 🛈 | 23 |
| peugeot citroen automobiles | 22 |
Cnrs
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| compounds useful for treating premature aging and in particular progeria | 132 | 2009 |
| methods for treating pancreatic cancer | 66 | 2010 |
| monoclonal antibodies to progastrin and their uses | 58 | 2009 |
| inhibitors of apoptosis and uses thereof | 50 | 2010 |
| combination of a bis-thiazolium salt or a precursor thereof and artemisinin or a derivat… 🛈 | 47 | 2008 |
| 2' and 3'-nucleoside prodrugs for treating flaviviridae infections | 45 | 2002 |
| d-amino acid compounds for liver disease | 41 | 2012 |
| modifying glycoprotein production in plants | 38 | 2007 |
| combination of (3s,3s') 4,4'-disulfanediylbis(3-aminobutane 1-sulfonic acid) and a secon… 🛈 | 35 | 2011 |
| optimized in vivo delivery system with endosomolytic agents for nucleic acid conjugates | 35 | 2010 |